Europe to launch a brain research project

December 3, 2007

The European Science Foundation said it will propose a comprehensive mental health research effort of a size similar to that of the Human Genome Project.

The proposal -- to be discussed during the Foundation's annual EuroBioForum in Lisbon, Portugal -- is aimed at making Europe the global leader of research in the critical role of neurotransmitters in brain disorders.

Foundation officials said the project would bring together the efforts of scientists from a broad array of specialized areas, such as biochemistry, molecular biology, psychopharmacology and imaging techniques.

Professor David Nutt of the University of Bristol will lead the project to develop new methods of identifying the release of neurotransmitters, such as serotonin and dopamine, in the brain. Researchers would thenbe better able to examine the role of neurotransmitters in major mental disorders, including depression and schizophrenia.

Despite the vast number of affected people, Nutt said, "We don't even know … whether serotonin levels are high or low in depressed people."

He said he believes the conference will help people from universities, governments, industry and funding organizations to "share ideas and contribute to key policy and funding decisions."

The EuroBioForum meeting will run Wednesday through Friday.

Copyright 2007 by United Press International


print this article email this article download pdf blog this article bookmark this article     Stumble it Digg this share on Facebook retweet share on Reddit add to delicious
Rate this story - 5 /5 (2 votes)


December 3, 2007 all stories

Comments: 0

5 /5 (2 votes)
  • Stumble this up

  • Digg this

  • share this

  • hide
  • Related Stories

  • Young adults' blood lead levels linked to depression, panic disorder
    created Dec 07, 2009 | popularity not rated yet | comments 0
  • Brain scans show distinctive patterns in people with generalized anxiety disorder
    created Dec 07, 2009 | popularity not rated yet | comments 0
  • Back to (brain) basics
    created Nov 03, 2009 | popularity not rated yet | comments 0
  • Why antidepressants don't work for so many
    created Oct 23, 2009 | popularity not rated yet | comments 0
  • Fine-tuning treatments for depression
    created Oct 18, 2009 | popularity not rated yet | comments 0



  • hide
  • Relevant PhysicsForums posts

  • Inflamed trapezius muscle
    created Dec 11, 2009
  • Nociceptors
    created Dec 05, 2009
  • Nanomaterials destroy cancer!
    created Nov 30, 2009
  • Nuclear Medicine
    created Nov 30, 2009
  • More from Physics Forums - Medical Sciences

Other News

Higher levels of protein hormone associated with lower risk of dementia, Alzheimer's disease

Medicine & Health / Diseases

created 13 minutes ago | popularity not rated yet | comments 0

Persons with higher levels of leptin, a protein hormone produced by fat cells and involved in the regulation of appetite, may have an associated reduced incidence of Alzheimer disease and dementia, according to a study in ...


Naturally skinny people have their own challenges

Medicine & Health / Health

created 3 minutes ago | popularity not rated yet | comments 0

Nancy Brueheim wishes she could break 100 pounds. Without working at it, Brueheim, who is 71 and stands 5-foot-2, fluctuates between 95 and 98 pounds.


Smaller is better for finger sensitivity

Medicine & Health / Neuroscience

created 2 hours ago | popularity not rated yet | comments 0

People who have smaller fingers have a finer sense of touch, according to new research in the Dec. 16 issue of The Journal of Neuroscience. This finding explains why women tend to have better tactile acuity than men, becaus ...


Time for a new view of late-life dementia

Medicine & Health / Diseases

created 2 hours ago | popularity 4 / 5 (1) | comments 0

Two new studies published in the December 16, 2009 issue of the Journal of the American Medical Association point to the need for a broader scientific perspective on late-life dementia, according to an editorial in the sa ...


Drug for Alzheimer's disease does not appear to slow cognitive decline

Medicine & Health / Medications

created 3 hours ago | popularity not rated yet | comments 0

Although there were promising results in a phase 2 trial, patients with mild Alzheimer disease who received the drug tarenflurbil as part of a phase 3 trial did not have better outcomes on measures of cognitive decline or ...